Details of the Drug

General Information of Drug (ID: DMLSKA6)

Drug Name

RG6209

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Phase 1	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	Clinical pipeline report, company report or official report of Roche